US2521311074
US2521311074
DexCom, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 31.74B EUR | 25.42B EUR | 24.23B EUR | 25.54B EUR |
Enterprise Value | 31.3B EUR | 25.71B EUR | 24.5B EUR | 26.01B EUR |
Valuation Multiples | ||||
Trailing P/E | 33.38x | 25.43x | 26.05x | 34.94x |
Forward P/E | 26.9x | -- | -- | -- |
Price to Sales | 6.39x | 5.12x | 5.03x | 7.04x |
Price to Book | 12.11x | 9.7x | 8.2x | 9.3x |
EV/Revenue | 6.3x | 5.17x | 5.09x | 7.17x |
EV/EBITDA | 22.31x | 16.49x | 16.56x | 22.83x |
Price to FCF (P/FCF) | 31.08x | 18.09x | 16.95x | 26.05x |
EV/FCF | 30.66x | 18.3x | 17.14x | 26.53x |
FCF Yield | 3.22% | 5.53% | 5.9% | 3.84% |